Mendelson is a health care veteran. He worked in the Office of Management and Budget during the Clinton administration, founded the consultancy Avalere Health and was most recently an operating partner at private equity firm Welsh, Carson, Anderson & Stowe.
Reporting to Scher, he’ll lead an initial team of about 20 people, based in Washington, and collaborate with the JPMorgan’s benefits team and bankers.
JPMorgan said it’s looking to partner with startups and existing companies, including its insurance carriers, CVS Health Corp.’s Aetna unit and Cigna Corp. It will invest in innovative businesses of all sizes, Mendelson said.
Clinical Outcomes
Morgan Health will take time to figure out its targets and plans to measure success against specific clinical outcomes, such as improvements in biomarkers for diabetes or cardiovascular health, he said. The venture will build on changes that Covid-19 accelerated in how people access health care and the needs the pandemic highlighted.
“The pandemic has accelerated focus on digital care, it has accelerated focus on health equity, it has accelerated focus on really repairing the fragmentation of the health-care delivery system,” Mendelson said.
As an example of potential improvements, Mendelson cited advanced primary care models that have been tested in Medicare. Those consist of “integrated teams that have nurses and pharmacists and other health-care professionals working with the physician to deliver the best care for the individual,” he said. “We want that kind of model for our employees.”
The project is picking up where Haven left off, Scher said. “I don’t think there would be Morgan Health without Haven,” he said.
This article was provided by Bloomberg News.